Long intergenic non-protein coding RNA 1338 (LINC01338)

LINC01338 is a long intergenic non-protein coding RNA gene that belongs to the class of long intergenic non-coding RNAs (lincRNAs), which are defined as non-coding RNAs greater than 200 nucleotides in length that do not overlap with annotated protein-coding genes. LincRNAs are increasingly recognized for their roles in regulating chromatin structure and gene expression, operating as scaffolds, decoys, or guides in various cellular processes. While well-studied lincRNAs are implicated in cell proliferation, signal transduction, and disease such as cancer, there is currently limited published functional or clinical data specific to LINC01338. Its alternate name LOC124901020 refers to its genomic annotation. The molecule is not an enzyme, receptor, transporter, or canonical therapeutic target and currently lacks documented interactions with drugs or use as a biomarker [1][5][7]. LINC01338 should not be confused with LINC01133, a different lincRNA with well-described oncogenic and tumor-suppressor roles in various cancers [2]. Most functional and disease-related evidence in lincRNA literature pertains to LINC01133 or other family members, not LINC01338. In summary, LINC01338 (LOC124901020) is a structurally annotated long intergenic non-protein coding RNA gene, primarily classified as a lincRNA with regulatory potential but not recognized as a therapeutic target, biomarker, or drug-interacting molecule in current scientific literature [1][5][7].

Other names

LINC01338LOC124901020

None documented; mechanisms are only described for better-studied lincRNAs, such as acting as molecular decoys or scaffolds, but this is not yet attributed to LINC01338